Vincent Woo
University of Manitoba(CA)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, Pancreatic function and diabetes, Hyperglycemia and glycemic control in critically ill and hospitalized patients
Most-Cited Works
- → Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes(2016)6,312 cited
- → The 2015 Canadian Hypertension Education Program Recommendations for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension(2015)694 cited
- → Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes(2008)691 cited
- → Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children(2018)578 cited
- → Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children(2020)575 cited
- → Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension(2016)467 cited
- → The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2 – therapy(2010)374 cited
- → Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes(2014)354 cited
- → Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial(2019)348 cited
- → SGLT2 Inhibitor–associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis(2016)332 cited